Add-on effects of statin in simeprevir, peginterferon plus ribavirin combination therapy for chronic hepatitis C.
Not Applicable
Recruiting
- Conditions
- Chronic hepatitis C
- Registration Number
- JPRN-UMIN000012878
- Lead Sponsor
- Hokkaido University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
Not provided
Exclusion Criteria
1. prior treatment containing telaprevir 2. pregnant or possibly pregnant 3. patients with fertile partner 4. patients allergic to ribavirin or other nucleoside analogues
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method